ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance.

Zhao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.